AACR forum to focus on new advancements in cancer management among women

The American Association for Cancer Research will host a media forum focusing on new advancements in the prevention and patient management of cancer among women. This forum will be held here as part of the AACR's Ninth Annual Frontiers in Cancer Prevention Research Conference, which is Nov. 7-10, 2010.

"Cancer affects one in three women in the United States, and even as we understand more about potential treatments, the best strategy remains preventing cancer in the first place," said Judy E. Garber, M.D., M.P.H., director of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute and president-elect of the AACR.

"The needs of women are unique in this area, and the American Association for Cancer Research is at the forefront of the search for answers," she added.

The media forum will take place on Tuesday, Nov. 9, 2010, at 12:00 p.m. ET in room 203A of the Pennsylvania Convention Center.

Reporters who cannot attend in person can participate using the following information:

•Dial-in (U.S. and Canada): 1-888-282-7404
•Dial-in (International): 1-706-679-5207
•Access Code: 18308730

The following research will be discussed and experts will be available to answer questions:

•Menopausal Hormone Therapy May Increase Risk of Ovarian Cancer
•Side Effects of Hormonal Breast Cancer Therapy Increased; May Affect Treatment Adherence
•Exercise May Reduce Risk of Endometrial Cancer
•Soy Isoflavones May Modify Risk of Breast Cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI models redefine TIL scoring in breast cancer but face challenges in real-world validation